Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations
- Status
- COMPLETED
- Phase
- PHASE2
High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Azacitidine and CAPOX in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
- Status
- COMPLETED
- Phase
- PHASE1
Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1
First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant Treatment of Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3